ALLERGAN USA, INC.
NORTH CHICAGO, IL

ALLERGAN USA, INC., NORTH CHICAGO

ALLERGAN USA, INC. is an Active company incorporated on February 3, 2006 with the registered number F06000000729. This Foreign for Profit company is located at 1 N. WAUKEGAN ROAD, NORTH CHICAGO, IL, 60064, US and has been running for nineteen years. There are currently three active principals.

KEY FACTS ABOUT ALLERGAN USA, INC.

  1. US Businesses
  2. Companies in Florida
  3. Palm Beach County Companies
Company name
ALLERGAN USA, INC.
Status
Active
Filed Number
F06000000729
FEI Number
201843604
Date of Incorporation
February 3, 2006
Age - 19 years
Home State
DE
Company Type
Foreign for Profit

ALLERGAN USA, INC. NEAR ME

Principal Address
1 N. WAUKEGAN ROAD,
NORTH CHICAGO,
IL,
60064,
US
Mailing Address
1 N. WAUKEGAN ROAD,
TAX DEPARTMENT AP34-3,
NORTH CHICAGO,
IL,
60064,
US

See Also

ALLER-FRIENDLY EATS, LLC ALLERGAN SALES, LLC ALLERGAN, INC. ALLERGEN SERVE LLC ALLERGENE LLC

Officers and Directors

The ALLERGAN USA, INC. managed by the three persons from North Chicago on following positions: Dire, Vice President, Trea

Scott T Reents

Position
Dire Active
From
North Chicago, IL, 60064
Scott T Reents Related Companies
  1. ABBVIE US LLC
  2. ABBVIE INC.
  3. PHARMACYCLICS LLC
  4. KELLER MEDICAL, INC.
  5. APTALIS PHARMA US, INC.
  6. AEROPHARM TECHNOLOGY, LLC
Find More →

Lindsey Bristow

Position
Vice President Active
From
North Chicago, IL, 60064
Lindsey Bristow Related Companies
  1. PHARMACYCLICS LLC
  2. APTALIS PHARMA US, INC.
  3. ABBVIE RESPIRATORY LLC
  4. ALLERGAN SALES, LLC
  5. ALLERGAN, INC.
  6. WARNER CHILCOTT SALES (US), LLC
Find More →

David R Purdue

Position
Trea Active
From
North Chicago, IL, 60064
David R Purdue Related Companies
  1. PHARMACYCLICS LLC
  2. KELLER MEDICAL, INC.
  3. APTALIS PHARMA US, INC.
  4. AEROPHARM TECHNOLOGY, LLC
  5. LIFECELL CORPORATION
  6. ALLERGAN, INC.
Find More →



Registered Agent is CORPORATE CREATIONS NETWORK INC

Address
801 US HIGHWAY 1, NORTH PALM BEACH, FL, 33408

Events

April 8, 2008
NAME CHANGE AMENDMENT

Annual Reports

2024
April 4, 2024
2023
April 28, 2023